Congruence pulls in $50M series A to build a team of 'drug hunters' to go after rare disease targets
A new biotech called Congruence Therapeutics snagged $50 million to build a new team of "drug hunters" focused on protein misfolding to go after rare diseases. Congruence Therapeutics just completed a ...
Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for patients and research breakthroughs. Congruence received a $5 million grant to ...
The congruence model for a business is a change management process that examines the performance of an organization based on how it operates as a system. It was developped in the 1980s by ...
BDC Capital's Thrive Venture Fund joined to lead the extension. Congruence Therapeutics has secured an additional $20 million CAD ($15 million USD) for its Series A round. The extension saw BDC ...
Managers have to understand their businesses to make them more efficient. Theoretical models are critical in this understanding because they provide a conceptual framework for analyzing organizational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results